🤰 Diabetes in Pregnancy includes pre-existing type 1 or type 2 diabetes and gestational diabetes mellitus (GDM). Blood glucose may fall early in pregnancy, but insulin resistance usually rises in the 2nd and 3rd trimester because of placental hormones 🌸. Good glycaemic control reduces maternal, fetal and neonatal complications 🩸.

📖 About

Gestational diabetes is diabetes first diagnosed during pregnancy.
Glycosuria is common in pregnancy because the renal glucose threshold is lower, so urine glucose alone is not diagnostic.
Placental hormones, including human placental lactogen, progesterone and cortisol, increase insulin resistance in later pregnancy.
Insulin requirements often rise in the 2nd and 3rd trimester.
After delivery, insulin resistance falls rapidly once the placenta is delivered.

🧬 Pathophysiology

Pregnancy is a state of progressive insulin resistance.
In susceptible women, pancreatic ß-cells cannot produce enough extra insulin to overcome this resistance.
This leads to maternal hyperglycaemia.
Glucose crosses the placenta, but maternal insulin does not.
The fetus responds by producing more insulin, which promotes growth and increases the risk of macrosomia and neonatal hypoglycaemia.

⚠️ Risk Factors for Gestational Diabetes

BMI above 30 kg/m².
Previous macrosomic baby weighing 4.5 kg or more.
Previous gestational diabetes.
First-degree relative with diabetes.
Family origin with higher diabetes prevalence, including South Asian, Black Caribbean and Middle Eastern backgrounds.

🔎 NICE Diagnostic Criteria for Gestational Diabetes

NICE recommends diagnosing gestational diabetes using a 75 g 2-hour oral glucose tolerance test if either threshold is met.

Test	Diagnostic threshold for GDM
Fasting plasma glucose	≥ 5.6 mmol/L
2-hour plasma glucose after 75 g OGTT	≥ 7.8 mmol/L

🧪 Screening

Screen women with risk factors using a 75 g 2-hour OGTT.
For most high-risk women, offer OGTT at 24–28 weeks.
If there was previous gestational diabetes, offer early self-monitoring of blood glucose or an early OGTT, then repeat testing at 24–28 weeks if early testing is normal.
Do not rely on glycosuria alone to diagnose gestational diabetes.
HbA1c may help identify pre-existing diabetes, but OGTT is used for NICE diagnosis of GDM.

🎯 Blood Glucose Targets in Pregnancy

Targets should be individualised and achieved without causing troublesome hypoglycaemia.

Timing	Target
Fasting glucose	< 5.3 mmol/L
1 hour after meals	< 7.8 mmol/L
2 hours after meals	< 6.4 mmol/L
During labour and birth	Usually 4.0–7.0 mmol/L

🛠️ Management

Provide care through a multidisciplinary diabetes-in-pregnancy team.
Give specialist dietary advice, including carbohydrate awareness and healthy eating.
Encourage safe physical activity if appropriate.
Teach regular capillary blood glucose monitoring.
If glucose targets are not met with diet and exercise, consider metformin.
If metformin is contraindicated, not tolerated or insufficient, offer insulin.
Insulin may be needed immediately if glucose is very high at diagnosis or if there are complications such as suspected macrosomia or hydramnios.

💊 Medication

Insulin: Safe and effective in pregnancy; used when targets are not met or hyperglycaemia is significant.
Metformin: May be used in pregnancy when benefits outweigh potential harms.
Other oral glucose-lowering drugs: Usually stopped in pre-existing diabetes and replaced with insulin, except metformin when appropriate.
Pre-existing diabetes: Requires specialist review of medication, retinal status, renal function and pregnancy risks.

👁️ Monitoring for Pre-existing Diabetes

Assess renal function and urinary albumin:creatinine ratio.
Offer retinal assessment because diabetic retinopathy can worsen during pregnancy.
Monitor blood pressure and urine protein because pre-eclampsia risk is increased.
Use ultrasound surveillance to monitor fetal growth and amniotic fluid volume.

👶 Fetal and Obstetric Monitoring

Offer serial ultrasound assessment of fetal growth and amniotic fluid volume.
Assess for macrosomia and polyhydramnios.
Discuss timing and mode of birth with the obstetric and diabetes team.
Consider shoulder dystocia risk if fetal macrosomia is suspected.

⚠️ Risks of Diabetes in Pregnancy

Maternal: Pre-eclampsia, operative delivery, worsening retinopathy in pre-existing diabetes, and future type 2 diabetes after GDM.
Fetal: Macrosomia, polyhydramnios, shoulder dystocia, birth trauma and stillbirth risk if control is poor.
Neonatal: Hypoglycaemia, respiratory distress, jaundice and admission to neonatal care.
Pre-existing diabetes: Poor early glycaemic control increases risk of congenital malformations and miscarriage.

🏥 Labour and Birth

Monitor capillary blood glucose regularly during labour.
Aim to keep glucose usually between 4.0 and 7.0 mmol/L during labour and birth.
Use local protocol for variable-rate IV insulin infusion if glucose is outside target or if clinically indicated.
Neonatal team should be aware because babies are at risk of hypoglycaemia after birth.

🍼 After Birth

Insulin requirements fall rapidly after delivery.
Women with gestational diabetes can usually stop glucose-lowering treatment immediately after birth unless hyperglycaemia persists.
Encourage breastfeeding where possible.
Check for persistent diabetes after pregnancy.
Give lifestyle advice because future type 2 diabetes risk is increased.

🔁 Postnatal Follow-Up After GDM

Offer fasting plasma glucose testing 6–13 weeks after birth, or HbA1c after 13 weeks if fasting glucose was not done.
Advise annual HbA1c testing thereafter to screen for type 2 diabetes.
Advise weight management, healthy diet and physical activity.
In future pregnancies, arrange early testing because recurrence risk is increased.

💡 Clinical Pearl:
Screen women with NICE risk factors, such as BMI above 30 kg/m², previous gestational diabetes, previous baby ≥4.5 kg, first-degree family history of diabetes, or higher-risk ethnic background. In the UK, most high-risk women are offered a 75 g OGTT at 24–28 weeks.

📚 Case Example

👩 A 32-year-old woman with BMI 34 kg/m² attends at 26 weeks. A 75 g OGTT shows fasting glucose 6.2 mmol/L and 2-hour glucose 9.8 mmol/L. ✅ Diagnosis: Gestational diabetes, because fasting glucose is ≥5.6 mmol/L and 2-hour glucose is ≥7.8 mmol/L. 🛠️ Management: Specialist dietetic advice, blood glucose monitoring, exercise advice if safe, and metformin or insulin if targets are not met. ⚠️ Delivery planning should consider fetal growth, macrosomia risk and neonatal hypoglycaemia risk.

🧠 Exam Pearls

NICE GDM diagnosis: fasting glucose ≥5.6 mmol/L or 2-hour OGTT ≥7.8 mmol/L.
Pregnancy glucose targets: fasting <5.3, 1-hour <7.8, 2-hour <6.4 mmol/L.
Glucose crosses the placenta; insulin does not.
Fetal hyperinsulinaemia causes macrosomia and neonatal hypoglycaemia.
After delivery, insulin resistance falls quickly because the placenta has been delivered.

📚 Summary

Diabetes in pregnancy requires early recognition, careful glucose monitoring and multidisciplinary care. NICE diagnoses gestational diabetes using a 75 g OGTT with fasting glucose ≥5.6 mmol/L or 2-hour glucose ≥7.8 mmol/L. Good control reduces risks such as pre-eclampsia, macrosomia, shoulder dystocia and neonatal hypoglycaemia.

Additional related clinical topics

Diabetes and Pregnancy

🧩 Diabetes in Pregnancy

Pre-existing diabetes:
- Type 1 → insulin dependent, autoimmune, usually diagnosed in youth.
- Type 2 → insulin resistance ± relative deficiency, associated with obesity.
Gestational diabetes (GDM):
- Diabetes diagnosed during pregnancy (not overt pre-existing).
- Typically detected in 2nd–3rd trimester via OGTT.
- Risk factors: age >25, BMI >30, previous GDM, macrosomic baby (>4.5kg), family history, non-Caucasian background, HIV positive.

⚠️ Risks in Pregnancy

For the Mother:
- Hypertension, pre-eclampsia, miscarriage, preterm labour.
- Hypoglycaemia unawareness (esp. in T1DM).
- Progression of retinopathy and nephropathy.
- Higher caesarean section rates.
- Increased lifetime risk of T2DM (esp. after GDM).
For the Baby:
- Macrosomia → shoulder dystocia, birth trauma.
- Congenital malformations (if poor control at conception).
- Neonatal hypoglycaemia (due to fetal hyperinsulinism).
- ↑ risk of obesity and T2DM in later life.

🛠️ Management Strategies

Preconception:
- Optimise HbA1c (<48 mmol/mol if safe).
- Weight optimisation, lifestyle advice.
- Stop unsafe meds (ACEi, statins, some oral hypoglycaemics).
- Folic acid 5 mg/day until 12 weeks.
During pregnancy:
- Frequent CBG monitoring (≥4x/day) or CGM/flash monitoring.
- Eye and renal screening early in pregnancy.
- OGTT at booking if risk factors.
- Insulin is mainstay (oral agents avoided except metformin if risk-benefit considered).
- Ultrasound & growth scans to monitor macrosomia/polyhydramnios.
Targets (NICE):
- Fasting: 5.0–7.0 mmol/L.
- Pre-meal: 4.0–7.0 mmol/L.
- Test blood ketones if hyperglycaemic or unwell.
If Type 1 Diabetes:
- Offer CGM (continuous glucose monitoring).
- Alternative: Flash glucose monitor (Libre).
If non–Type 1 Diabetes:
- CGM may still be offered if poor control.
- Increase monitoring if meds adjusted.

🍼 Postpartum Care

Mother:
- Insulin needs usually fall rapidly after delivery.
- Check fasting glucose at 6 weeks postpartum (esp. after GDM).
- Half of women with GDM develop T2DM long-term → lifelong screening needed.
Baby:
- Monitor for neonatal hypoglycaemia and respiratory distress.
- Ongoing paediatric review for growth and metabolic risk.
Breastfeeding:
- Encouraged – improves maternal glycaemia and reduces child’s diabetes risk.
- May require reduced insulin doses due to increased energy demands.

📚 Teaching Pearls

Poor glycaemic control at conception → highest risk of congenital malformations.
ACE inhibitors & statins are teratogenic – must be stopped preconception.
Metformin sometimes continued in GDM or T2DM, but insulin is gold standard.
Always think macrosomia → shoulder dystocia risk in OSCE stations.
Women with GDM require lifelong annual diabetes screening.

🔗 References

NICE NG3 – Diabetes in Pregnancy

The content on this website is provided for educational and informational purposes only to support exam preparation (e.g., MLA, MRCP, USMLE) and learning. This is NOT medical advice, diagnosis, treatment, or professional guidance. It does not replace consultation with a qualified healthcare professional, official guidelines (e.g., NICE, GMC, BNF), or supervised clinical practice. Always verify information with current, authoritative sources. Makindo and its contributors accept no liability for any reliance on this content, including errors, omissions, or any resulting harm, loss, or consequences. By using this site, you agree to these terms.

Gestational Diabetes Mellitus ✅